Home > Healthcare > Analytical Instruments > Molecular Analysis > Large Molecule Bioanalytical Technologies Market

Large Molecule Bioanalytical Technologies Market Size

Report ID: GMI8333
Published Date: Feb 2024
Report Format: PDF

Download Free Sample

Large Molecule Bioanalytical Technologies Market Size

Large Molecule Bioanalytical Technologies Market size was valued at USD 8.3 billion in 2023 and is estimated to expand at over 10.4% CAGR from 2024 to 2032. Large molecule bioanalytical technologies refer to a set of analytical techniques and methodologies used to study and characterize large biological molecules such as proteins, peptides, nucleic acids (DNA, RNA), antibodies, and other biologics. These technologies are essential for understanding the structure, function, interaction, and quantity of these molecules in biological systems.

To get key market trends

Download Free Sample

The increasing prevalence of chronic diseases is a significant driver for the large molecule bioanalytical technologies market. For instance, according to the International Diabetic Federation (IDF), in 2021, approximately 537 million adults lived with diabetes worldwide, with predictions suggesting that this figure will reach 643 million by 2030. Therefore, large molecule bioanalytical technologies are required for accurate diagnosis, monitoring, drug development, biomarker discovery, and personalized treatment strategies.

Large Molecule Bioanalytical Technologies Market Report Attributes
Report Attribute	Details
Base Year:	2023
Large Molecule Bioanalytical Technologies Market Size in 2023:	USD 8.3 Billion
Forecast Period:	2024 – 2032
Forecast Period 2024 – 2032 CAGR:	10.4%
2024 – 2032 Value Projection:	USD 19.9 Billion
Historical Data for:	2018 – 2023
No. of Pages:	160
Tables, Charts & Figures:	296
Segments covered:	Offering, Technology, Application, End-use and Region
Growth Drivers:	Increasing demand for biologics & biosimilars Rising advancements in bioanalytical technology Increasing prevalence of chronic diseases Increasing research and development in the omics sector
Pitfalls & Challenges:	High costs associated with these technologies Lack of standardization and validation

Learn more about the key segments shaping this market

Download Free Sample

Furthermore, increasing demand for biologics & biosimilars, rising advancements in bioanalytical technology, increasing research and development in the multi-omics sector, which is set to reach 12.2 billion by 2032, increasing drug development and clinical trials, rising adoption of biomarkers-based diagnostics, are the contributing factors stimulating the growth of the market.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of large molecule bioanalytical technologies reached USD 8.3 billion in revenue in 2023 and is set to surpass USD 19.9 billion by 2032, owing to the growing prevalence of chronic diseases globally.

The chromatography segment accounted for USD 2.1 billion in revenue in 2023, due to its increasing use to provides high-resolution separation of complex mixtures of large biomolecules.

North America market generated USD 3.4 billion in revenue in 2023, attributed the presence of a robust infrastructure for technology development across the region.

Some of the top industry players are Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Cergentis B.V., Danaher Corporation, Halo Labs, Inc, Intertek Group plc, Laboratory Corporation of America Holdings,Shizmandu Corporation, and SOLVIAS AG.